/Abbott%20Laboratories%20vials%20and%20Logo-by%20Melniov%20Dmitriy%20via%20Shutterstock.jpg)
Abbott has underperformed the broader market over the past year, but Wall Street analysts are optimistic about the stock’s prospects.
Medtronic has underperformed the broader market over the past year, but Wall Street analysts are still moderately bullish about the stock’s prospects.
Despite Baxter International’s relatively underwhelming performance over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.
Boston Scientific has significantly outperformed the broader market YTD, and Wall Street analysts are still bullish about the stock’s prospects.
These three thematic ETFs could be potent growth vehicles in years to come.
These funds focus on U.S.-based companies in relatively stable industries.
Markets have been known to have periods of "nasty" industry group rotation. Get ahead of the curve with these 3 under-the-radar groups.
Smart Beta ETF report for XHE
Sector ETF report for XHE